Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Citizen Meds vs Silhouette MD

Citizen Meds
Graded #254

Lower grade

vs+5.700000000000003
Silhouette MD
Graded #129

Higher grade

The verdict

Silhouette MD takes it — 69.4/100 to 63.7/100.

Silhouette MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Concierge-style GLP-1 telehealth offering compounded semaglutide and tirzepatide in both injectable and oral forms, with provider oversight and full-service support included on every plan.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSilhouette MD +4
70
74
Dose & formulationSilhouette MD +21
54
75
Clinical oversightCitizen Meds +2
79
77
Labs & monitoringSilhouette MD +2
52
54
FulfillmentSilhouette MD +5
62
67
Contract termsEven
55
55
Citizen Meds · left barSilhouette MD · right bar

The numbers

MetricCitizen MedsSilhouette MD
WeighScore63.7/10069.4/100
GradeCC
Scorecard rank#254#129
Semaglutide$125/mo (0.25 mg dose, compounded)$149/mo (compounded)
Tirzepatide$185/mo (2.5 mg dose, first-month rate, compounded)$299/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Citizen Meds

Graded #254 · C

Strengths

  • Semaglutide confirmed from product listings
  • New-patient discount available (code NEWPATIENT10)

Where it loses points

  • No visible LegitScript or PCAB accreditation
  • State availability not disclosed
  • About page returns a 404
  • Limited overall transparency
Silhouette MD

Graded #129 · C

Strengths

  • Compounded semaglutide and tirzepatide in both injectable and oral formulations
  • Concierge-level support — monitoring, expert guidance, and check-ins included on every plan
  • Transparent, published pricing starting at $149/mo for semaglutide injection
  • Prescriptions issued and fulfilled by licensed clinical partner OpenLoop Health

Where it loses points

  • Tirzepatide ($299/mo) and oral options ($263–$325/mo) priced above many compounded competitors
  • State availability not published
  • Newer brand with limited independent review history
  • Medications are compounded, not FDA-approved brand-name

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard